WeVote
Log In

Bill

Bill

A 2253

Relates to authorizing and establishing a training program for paramedics for the administration of buprenorphine

2025 Regular Session Introduced by Demond Meeks and 2 co-sponsors

New York bill authorizes paramedics to administer buprenorphine during emergency response to opioid overdose via expanded training program.

REFERRED TO HEALTH
0
WeVote Research Nonpartisan
Bill Summary · A 2253

Legislative bill overview

Bill A 2253 establishes and authorizes a training program enabling paramedics in New York to administer buprenorphine, a medication used to treat opioid use disorder. The bill expands the scope of practice for emergency medical services personnel to include this medication-assisted treatment in pre-hospital settings.

Why is this important

Opioid overdose deaths remain a significant public health crisis, and buprenorphine is an evidence-based treatment that reduces cravings and withdrawal symptoms. Enabling paramedics to administer buprenorphine during emergency response could increase early intervention access and potentially reduce overdose fatalities and subsequent emergency department burden.

Potential points of contention

  • Scope of practice expansion: Questions about whether paramedics have adequate training and oversight to safely administer a controlled substance and manage potential contraindications or adverse reactions
  • Program standards and liability: Concerns about training requirements, certification standards, quality control, and who bears liability if administration causes harm
  • Implementation costs: Uncertainty about funding for training programs, program administration, and ongoing supervision across New York's diverse EMS systems

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.